Doç. Dr. KADİR ESER
- Yöksis ID 129607
- Researcher ID
- ORCID ID 0000-0001-8666-6177
- Scopus ID
- Scholar ID
- E-posta kadireser@mersin.edu.tr
- Dahili Telefon +90 324 361 00 01 -
Birim
TIP FAKÜLTESİ
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
İÇ HASTALIKLARI ANABİLİM DALI
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
İÇ HASTALIKLARI ANABİLİM DALI
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Tıbbi Onkoloji (İç Hastalıkları)
Tıbbi Onkoloji (İç Hastalıkları)
Son 5 Makale
Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring
JOURNAL OF CLINICAL MEDICINE, vol. 14, no. 5, pp. 1742– Link 2025
HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study
Medicina, vol. 60, no. 12, pp. 2087–2098 Link 2024
Clinical, Biochemical, and Radiological Retrospective Analysis in Patients with Adrenal Incidentaloma – A Secondary Publication
Proceedings of Anticancer Research, vol. 8, no. 1, pp. 129–139 Link 2024
Evaluation of Biosimilar Trastuzumab MYL-1401O in HER2-Positive Breast Cancer
AMERICAN JOURNAL OF MANAGED CARE, vol. 29, no. 2, pp. e36–e42 Link 2023
Investigation of Regorafenib Efficacy in Patients with Metastatic Colorectal Carcinoma in Relation to the Delivered Dose Intensity/Body Surface Area
Journal of oncological sciences, vol. 8, no. 1, pp. 34–42 Link 2022
JOURNAL OF CLINICAL MEDICINE, vol. 14, no. 5, pp. 1742– Link 2025
HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study
Medicina, vol. 60, no. 12, pp. 2087–2098 Link 2024
Clinical, Biochemical, and Radiological Retrospective Analysis in Patients with Adrenal Incidentaloma – A Secondary Publication
Proceedings of Anticancer Research, vol. 8, no. 1, pp. 129–139 Link 2024
Evaluation of Biosimilar Trastuzumab MYL-1401O in HER2-Positive Breast Cancer
AMERICAN JOURNAL OF MANAGED CARE, vol. 29, no. 2, pp. e36–e42 Link 2023
Investigation of Regorafenib Efficacy in Patients with Metastatic Colorectal Carcinoma in Relation to the Delivered Dose Intensity/Body Surface Area
Journal of oncological sciences, vol. 8, no. 1, pp. 34–42 Link 2022
Son 5 Bildiri
AKCİĞER KANSERLİ HASTALARDA F-18-FDG PET/BT İLE SAPTANAN PANKREATİK HİPERMETABOLİK LEZYONLARIN PATOLOJİK KORELASYONU
36. Ulusal Nükleer Tıp Kongresi (08.05.2024 - 12.05.2024) 2024
The Role of lncRNA H19 in the Resistance of Ovarian Cancer Cells to Cisplatin Therapy
6th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2023) (11.10.2023 - 13.10.2023) Link 2023
HER2-Pozitif Meme Kanserinde Biyobenzer Trastuzumab MYL-1401O'nun Etkinlik ve Güvenlik Değerlendirmesi
6. Ulusal İmmünoterapi ve Onkoloji Kongresi (19.10.2022 - 23.10.2022) 2022
Böbrek Tümörlerinde Tedavi
3. Uluslararası & 7. İlaç ve Tedavi Kongresi (21.09.2022 - 24.09.2022) 2022
HER2 pozitif meme kanserinde farklı neoadjuvan tedavi verilen hastalarda patolojik yanıt ve PFS’nin değerlendirilmesi
9. Türk Tıbbi Onkoloji Derneği Kongresi (18.05.2022 - 22.05.2022) 2022
36. Ulusal Nükleer Tıp Kongresi (08.05.2024 - 12.05.2024) 2024
The Role of lncRNA H19 in the Resistance of Ovarian Cancer Cells to Cisplatin Therapy
6th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2023) (11.10.2023 - 13.10.2023) Link 2023
HER2-Pozitif Meme Kanserinde Biyobenzer Trastuzumab MYL-1401O'nun Etkinlik ve Güvenlik Değerlendirmesi
6. Ulusal İmmünoterapi ve Onkoloji Kongresi (19.10.2022 - 23.10.2022) 2022
Böbrek Tümörlerinde Tedavi
3. Uluslararası & 7. İlaç ve Tedavi Kongresi (21.09.2022 - 24.09.2022) 2022
HER2 pozitif meme kanserinde farklı neoadjuvan tedavi verilen hastalarda patolojik yanıt ve PFS’nin değerlendirilmesi
9. Türk Tıbbi Onkoloji Derneği Kongresi (18.05.2022 - 22.05.2022) 2022